Global injectable drug delivery market is expected to grow at a CAGR value of 11.5% by 2024

Festive Month Offer –

20% discount on purchase of reports from 1st October to 31st October.

https://www.researchtrades.com/discount/1277068

For more offers post 31st October, kindly contact us. * Terms & Conditions apply!!

Contact No. : +16269994607 (US), /+91 7507349866 (IND)

Email: sales@researchtrades.com

 

Report Overview:

In this region, global injectable drug delivery is projected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Based on geography, the global injectable drug delivery market is segmented into 5 geographical regions, such as,

North America,

South America,

Europe,

APAC,

MEA,

 

Global injectable drug delivery market competition by top players including-

Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as

Gerresheimer AG,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.,

Bespak, Antares Pharma,

Elcam Medical,

Haselmeier,

 

Get Exclusive sample copy @ https://www.researchtrades.com/request-sample/1277068

 

The global injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

 

The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

 

Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.

 

The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

 

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

 

The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

 

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

 

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

 

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

 

TABLE OF CONTENTS

 

  1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL INJECTABLEDRUG DELIVERY MARKET

1.2. CURRENCY AND PRICING

1.3. LIMITATION

1.4. MARKETS COVERED

 

  1. MARKET SEGMENTATION

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

….

Browse This Report @ https://www.researchtrades.com/report/global-injectable-drug-delivery-market-analysis-companies-profiles-size-share-growth-trends-and-forecast-to-2024/1277068

 

Who we are

Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

 

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: